We first learned about 100 nm exosomes studded with high levels of spike protein following the Pfizer BNT162b2 in this paper [Bansal S, Perincheri S, Fleming T, Poulson C, Tiffany B, Bremner RM, Mohanakumar T. Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines. J Immunol. 2021 Nov 15;207(10):2405-2410. doi: 10.4049/jimmunol.2100637.] The highest levels occurred 14 days after the second dose of Pfizer and the exosomes were CD9 positive indicating they originated from macrophages. Foamy M1-like Macrophages that generate trained immunity (the most important protection the body offers against pathogens/tumors etc) release the 100 nm HERV-K102 particles (CD9 exosomes) after 7 days. Serious adverse events like shedding are easily characterized as microclotting/vasculitis events occuring within 48 hours of vaccination of COVID-19 vaccines (can be 1st or 2nd doses) due to shedding from the recently fully vaccinated vaccinators. In addition serious adverse events occurring after 60 days can also be due to shedding. The data from the McCullough research team indicates the reverse transcriptase and integrase of HERV-K102 was likely responsible for the integration of the 22 bp spike oncogenic fragment found in the bladder cancer (identical to the spike sequence in the Pfizer construct), consistent with the notion that shedding (bioweaponized HERV-K102) may highly increase the risk of integration meaning genetic modification of the host. This risk while more frequent in people who got the mRNA shot, also applies to the unvaccinated. The finding of more evidence of the persistence of the plasmids along with the spike protein longer term in the second paper by the McCullough research group and the probable shedding event on October 28, 2021, strongly supports the contention that the dirty Pfizer LNPs (Process 2) carries a risk of genetic modification of the host. HERV-K102 is a non-pathogenic foamy retrovirus and its ability to increase its own integration levels was detected in a special cohort of HIV-exposed seronegative commercial sex workers who were resistant to HIV-1 acquisition [Laderoute et al, 2015]. HERV-K102 has also been found to increase its copy number associated with overall survival in lung adenocarcinoma patients [Ng KW et al, Nature Medicine 2023]. BTW that is precisely what retroviruses do.
Thank You, Dr. Laderoute. I am sorry to understand this so clearly. It is truly diabolical. ;-(
Marian, are you saying that shedding can result in exosomes or other particle entering the nucleus and modifying our dna?
We first learned about 100 nm exosomes studded with high levels of spike protein following the Pfizer BNT162b2 in this paper [Bansal S, Perincheri S, Fleming T, Poulson C, Tiffany B, Bremner RM, Mohanakumar T. Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines. J Immunol. 2021 Nov 15;207(10):2405-2410. doi: 10.4049/jimmunol.2100637.] The highest levels occurred 14 days after the second dose of Pfizer and the exosomes were CD9 positive indicating they originated from macrophages. Foamy M1-like Macrophages that generate trained immunity (the most important protection the body offers against pathogens/tumors etc) release the 100 nm HERV-K102 particles (CD9 exosomes) after 7 days. Serious adverse events like shedding are easily characterized as microclotting/vasculitis events occuring within 48 hours of vaccination of COVID-19 vaccines (can be 1st or 2nd doses) due to shedding from the recently fully vaccinated vaccinators. In addition serious adverse events occurring after 60 days can also be due to shedding. The data from the McCullough research team indicates the reverse transcriptase and integrase of HERV-K102 was likely responsible for the integration of the 22 bp spike oncogenic fragment found in the bladder cancer (identical to the spike sequence in the Pfizer construct), consistent with the notion that shedding (bioweaponized HERV-K102) may highly increase the risk of integration meaning genetic modification of the host. This risk while more frequent in people who got the mRNA shot, also applies to the unvaccinated. The finding of more evidence of the persistence of the plasmids along with the spike protein longer term in the second paper by the McCullough research group and the probable shedding event on October 28, 2021, strongly supports the contention that the dirty Pfizer LNPs (Process 2) carries a risk of genetic modification of the host. HERV-K102 is a non-pathogenic foamy retrovirus and its ability to increase its own integration levels was detected in a special cohort of HIV-exposed seronegative commercial sex workers who were resistant to HIV-1 acquisition [Laderoute et al, 2015]. HERV-K102 has also been found to increase its copy number associated with overall survival in lung adenocarcinoma patients [Ng KW et al, Nature Medicine 2023]. BTW that is precisely what retroviruses do.